Toll-Free: 855-947-0707
Phone: 202-796-6662
Kennedy Hodges L.L.P.

Drug Prescribed to Treat Rare Disease may have Caused Cancer

Comments (0)

A class action lawsuit has recently been filed against Genzyme Corporation after a man claims it distributed and sold untested and impure drugs. The man suffers from Gaucher's disease, which is a rare disease in which a fatty substance accumulates in cells and some organs. It can cause an enlarged spleen and liver, liver malfunction, neurologic complications, anemia, and many other complications.

Around 2009, the man was prescribed Cerezyme, which was described as a miracle drug for many patients suffering from Gaucher's disease. The man claims that between 2009 and 2011, the drug company which made Cerezyme substituted the drug with experimental doses of an untested drug that had been intentionally mislabeled. The plaintiff also claims that the drug was contaminated with a viral pathogen known to be dangerous to humans.

Finally, the man also claims the drug was diluted below FDA-approved levels because of a drug shortage. He claims that due to the contamination of the drug with a virus, Genzyme could not meet customer demand. Therefore, doses were cut to less than a third of the actual drug. Genzyme acknowledged the shortage, telling patients that they could safely so without one or two treatments.

In 2012, the man was diagnosed with myeloma, which is a cancer of the plasma cells. He claims that the impure and ineffective drug Cerezyme caused his cancer, which is incurable. Unfortunately, drug contamination and drug tampering is nothing new for drug companies. Although this case hasn't been decided, there are numerous instances in the past of drug companies doing anything to make a profit, including sacrificing customer safety.

If you have been injured by a defective drug, call the defective drug attorneys at Kennedy Hodges at 713-489-9493 or 800-391-9935. We will help you obtain compensation for your damages. Call today to learn more.

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.